ERBB2 and breast cancer: Amplification and overexpression of v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (ERBB2, also known as HER2) occurs in up to 20% of breast cancers and defines a distinct clinical and molecular subtype1–3.